We are Epilepsy Society. The UK's leading charity for epilepsy research and support.
Due to current circumstances in relation to the coronavirus some of our services have been reduced with our staff working from home. Despite this our top priority at Epilepsy Society is to support people living with epilepsy. You may notice a slight change in our communications. For the time being, we will focus our efforts on making sure you have all the information you need from us to help you as best we can in the current climate.
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Join us to make your voice heard and help improve the lives of people with epilepsy. Through our advocacy campaigns we've spread awareness of the impact of epilepsy on people's lives and protected people with epilepsy by lobbying government.
The Government has promised that Ofcom will have “a suite of enforcement powers” to tackle online abuse against people with epilepsy.
We are thrilled to see that the Daily Express is today (19 February 2021) backing our Zach’s Law campaign to bring to justice internet trolls who send flashing images to people with epilepsy in order to trigger seizures.
The Epilepsy Society has welcomed the publication of data from a new valproate registry but called for it to be expanded to include all anti-epilepsy drugs.
Epilepsy Society is launching a new campaign - ‘Safe Mum, Safe Baby’ - calling for safer epilepsy medications in pregnancy.
Following publication of a review highlighting the risks linked to some epilepsy medications during pregnancy, our Medical Director, Professor Ley Sander, has written a letter to support women and girls requesting a review of their medication and an urgent referral to a neurologist if they are planning to become pregnant.
Please read our update from the DHSC, reassuring people with epilepsy that they are included in priority group 6 for the Covid-19 vaccine. Also included is our downloadable vaccine letter to give to your GP.
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
You can call our helpline on 01494 601 400.
Our Helpline is open five days a week, Monday to Friday 9am to 4pm, (Wednesday 9am to 7.30pm).
You can also reach us by email
Please support us.
In these challenging times, charities like Epilepsy Society rely on donations to ensure vital services for our beneficiaries can continue. If you can spare a donation or pledge a monthly gift, you will be helping to ensure we continue to support everyone affected by epilepsy. Thank you.